GLYZIMAC TOTAL 60 TABLET

Product Description

GLYZIMAC TOTAL 60 TABLET is a powerful triple-drug combination for effective management of Type 2 Diabetes Mellitus. It contains Gliclazide, Pioglitazone, and Metformin Hydrochloride, each working synergistically to improve insulin sensitivity, control blood glucose levels, and reduce insulin resistance.

Formulated for once-daily dosing, GLYZIMAC TOTAL 60 helps patients achieve better glycemic control with fewer tablets, supporting long-term diabetes management protocols in hospitals, clinics, and retail settings.

Manufactured in WHO-GMP certified facilities, this formulation is a reliable choice for pharmaceutical distributors, hospital supply chains, and bulk medicine buyers seeking high-demand anti-diabetic medications.

Key Benefits:

• Triple-action formula for enhanced glycemic control

• Reduces fasting and postprandial blood sugar effectively

• Improves insulin sensitivity and decreases hepatic glucose production

• Ideal for monitored long-term diabetes treatment plans

Applications:

• Used in the treatment of Type 2 Diabetes Mellitus

• Suitable for patients requiring multi-drug oral therapy

• Prescribed in both outpatient and inpatient diabetic care settings

Why Choose GLYZIMAC TOTAL 60?

• Combines three proven anti-diabetic agents in a convenient single tablet

• Trusted by endocrinologists and diabetologists

• Available in bulk, with competitive pricing for distributors and retailers